article thumbnail

MHRA revamps UK clinical trial regulation with the promise of faster timelines

Pharmaceutical Technology

This week, the Medicines and Healthcare products Regulatory Agency (MHRA) is introducing major changes to clinical trial regulation in the UK with expedited timelines at several stages. The new framework will introduce a legal mandate to register a trial in the World Health Organisation (WHO) public register.

article thumbnail

Biggest overhaul of UK clinical trial regulation for 20 years

Drug Discovery World

A series of new measures will be introduced by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to make it faster and easier to gain approval and run clinical trials in the UK. For example, the regulatory and ethics reviews of clinical trial applications will be integrated.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Clinical Trial Data: Navigating Audit Trail Data Regulations and Accessibility Challenges 

VirTrial

Data is the single most important thing in a clinical trial. The data serves as the cornerstone for critical decisions determining the fate of therapies and the performance of trials. Study data is always subject to scrutiny by regulators, which further highlights its importance.

article thumbnail

UK regulator cuts late-stage clinical trial approval time to two weeks

Drug Discovery World

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has revealed plans to reduce the time taken to approve the lowest-risk clinical trials by more than 50%. It will reduce the time taken to get the lowest-risk clinical trials up and running without undermining patient safety.”

article thumbnail

2022 in review: Regulation starts to catch up with AI in pharma

Pharmaceutical Technology

But as the field grows in leaps and bounds, many authorities have prioritised the release of new guidelines, frameworks, and regulations to keep pace with these advances. This could spell high-stake consequences for consumers whose privacy and safety could be at risk if AI models are not regulated. Major AI deals in 2022.

article thumbnail

AI and machine learning: A new era for clinical trials

Drug Discovery World

Fiona Maini , Senior Director Global Compliance & Strategy, at Medidata looks at the rise of artificial intelligence (AI) and machine learning (ML) within life sciences and the applications for the technology in clinical trials.

article thumbnail

National Commission for Homoeopathy notifies BHMS regulations

AuroBlog - Aurous Healthcare Clinical Trials blog

The National Commission for Homoeopathy has prepared a regulation defining a structure to the Bachelor of Homoeopathic Medicine and Surgery (BHMS) course with changes including incorporation of a methodology to supplement modern advancement, research and technology in Homoeopathy (SMART-Homoeopathy).